Sun Pharmaceutical Industries Ltd.

Pharmaceuticals
India
2016 Revenue (US$ Millions)$4,653
Revenue Growth (%)10.85%
Net Income (US$ Millions)$937
Earnings Per Share (US$)$0.43
EPS Growth Rate (%)53.44%
Profit Margin20.14%
Total Equity (US$ Millions)$5,398
Return on Equity (%)19.28%
Long Term Debt (US$ Millions)$212
Debt To Equity Ratio (%)0.04%
Total Assets (US$ Millions)$9,048
Current Assets (US$ Millions)$4,855
Current Liabilities (US$ Millions)$2,635
Cost of Goods Sold (US$ Millions)$755
Inventory Turnover0.77